Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2425559
Max Phase: Preclinical
Molecular Formula: C20H20ClF3N2O3
Molecular Weight: 428.84
Molecule Type: Small molecule
Associated Items:
ID: ALA2425559
Max Phase: Preclinical
Molecular Formula: C20H20ClF3N2O3
Molecular Weight: 428.84
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)(C)[C@H](NC(=O)c1cc(Cl)ccc1O)C(=O)Nc1cccc(C(F)(F)F)c1
Standard InChI: InChI=1S/C20H20ClF3N2O3/c1-19(2,3)16(26-17(28)14-10-12(21)7-8-15(14)27)18(29)25-13-6-4-5-11(9-13)20(22,23)24/h4-10,16,27H,1-3H3,(H,25,29)(H,26,28)/t16-/m1/s1
Standard InChI Key: BLSAEMJLBUGXBF-MRXNPFEDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 428.84 | Molecular Weight (Monoisotopic): 428.1115 | AlogP: 4.85 | #Rotatable Bonds: 4 |
Polar Surface Area: 78.43 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.66 | CX Basic pKa: | CX LogP: 5.62 | CX LogD: 5.43 |
Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.65 | Np Likeness Score: -1.05 |
1. Imramovský A, Jorda R, Pauk K, Rezníčková E, Dušek J, Hanusek J, Kryštof V.. (2013) Substituted 2-hydroxy-N-(arylalkyl)benzamides induce apoptosis in cancer cell lines., 68 [PMID:23981532] [10.1016/j.ejmech.2013.08.009] |
Source(1):